[Clinical Application of Subcutaneous Nephrovesical Bypass System].

Jun Li,Xiao-feng Wang
DOI: https://doi.org/10.3969/j.issn.1671-167x.2010.04.026
2010-01-01
Abstract:OBJECTIVETo evaluated the subcutaneous nephrovesical bypass carried out in patients with ureter obstruction and improve the quality of life of patients with palliative definitive percutaneous nephrostomy.METHODSA total of 36 patients with advanced cancer receiving 45 subcutaneous nephrovesical bypass tubes were included in the study. Uronephrosis ranged from 1.8-5.2 cm, serum creatinine 73-760 micromol/L,and glomerular filtration rate (GFR) 19-26 mL/min. The obstruction was proved to be complete by retrograde pyelography. The nephrovesical stents were inserted utilizing percutaneous access to both of the kidney and bladder,and a subcutaneous tunnel was created between the two sites. B-ultrasound, KUB (kidneys, ureters, and bladder), serum creatinine test and GFR were carried out 72 hours after operation.RESULTSUrinary diversion operations were successful in the 36 patients, uronephrosis ranged from 0-1.8 cm, all stents were in position, serum creatinine 72-173 micromol/L, GFR 25-40 mL/min after the operation, and the bypass functioned well in 45 stents for 67 to 481 days of the follow-up.CONCLUSIONSubcutaneous nephrovesical bypass can protect renal function of patients suffering from ureteral obstruction by simple and minimum invasive operation; it can also reduce complications caused by percutaneous nephrostomy and improve the patient's life quality.
What problem does this paper attempt to address?